KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX )

Go back to KeyBanc Reiterates Overweight Rating on Recursion Pharmaceuticals (RXRX )
(NASDAQ: RXRX) Delayed: 3.22 -0.22 (6.4%)
Previous Close $3.44    52 Week High
Open $3.42    52 Week Low
Day High $3.45    P/E N/A 
Day Low $3.21    EPS
Volume 14,176,971